Almorexant; ACT 078573
Product Detail
Product Tags
| Pack Size | Availability | Price (USD) |
Chemical Name:
(2R)-2-((1S)-6,7-dimethoxy-1-{2-(4-(trifluoromethyl)phenyl)ethyl}-3,4-dihydroisoquinolin-2(1H)-yl)-N-methyl-2-phenylacetamide
SMILES Code:
CNC(=O)[C@H](N1CCc2cc(OC)c(OC)cc2[C@@H]1CCc3ccc(cc3)C(F)(F)F)c4ccccc4
InChi Code:
1S/C29H31F3N2O3/c1-33-28(35)27(20-7-5-4-6-8-20)34-16-15-21-17-25(36-2)26(37-3)18-23(21)24(34)14-11-19-9-12-22(13-10-19)29(30,31)32/h4-10,12-13,17-18,24,27H,11,14-16H2,1-3H3,(H,33,35)/t24-,27+/m0/s1
InChi Key:
DKMACHNQISHMDN-RPLLCQBOSA-N
Keyword:
871224-64-5;CAS:871224-64-5;CAS:871224-64-5;ACT078573;ACT 078573;ACT-078573;Almorexant
Solubility: Soluble in DMSO
Storage: Dry, dark and at 0 - 4 C for short term (days to weeks) or -20 C for long term (months to years).
Description:
Almorexant (ACT 078573) is an orally effective and competitive dual orexin receptor antagonist.
Target: orexin receptor


![7-Chloro-5-(4-chloro-2-fluorophenyl)-2,3-dimethylpyrido[3,4-b]pyrazine](https://www.caerulumpharm.com/uploads/CAS2738495-26-4结构图.png)
![1H-Pyrazolo[3,4-d]pyrimidine, 6-chloro-1-[[4-[1-(1-methylethyl)-4-(trifluoromethyl)-1H-imidazol-2-yl]phenyl]methyl]-](https://www.caerulumpharm.com/uploads/20240603134133.jpg)
.png)
![Benzonitrile, 4-[5-(trifluoroMethyl)-1H-iMidazol-2-yl]-](https://www.caerulumpharm.com/uploads/CAS33469-11-3结构图.png)
